JUL 06, 2017 4:00 PM PDT

Cancer Metastasis Caught on Film

WRITTEN BY: Xuan Pham

For the first time, scientists have captured on film cancer metastasis at the single-cell level in a mouse.

Image credit: Pixabay.com

"One of the biggest difficulties in studying cancer," said Hiroki Ueda, the study’s co-senior author, "is that tumor metastasis is started by just a few metastasized cells. Our new method makes it possible to image the whole body down to the individual cell level, and therefore we can detect cancer at spatial resolutions beyond what is possible using other current imaging techniques."

Using single-cell imaging techniques, scientists from the RIKEN Quantitative Biology Center in Japan collected data from individual cancer molecules. They combined this with a newly engineered labeling agent called CUBIC (clear unobstructed brain/body imaging cocktail).

The technique was tested on mice that were modified to have fluorescent cancer cells. Once the disease had progressed, the team applied the new imaging techniques to turn the animals’ organs transparent. This enabled the visualization of the individual cells as it multiplied and spread throughout the body.

"The images reveal cancerous colonies in enough detail to calculate their shapes, volumes, and distributions - characteristics critical to distinguishing between patterns of metastasis,” said Dr. Ueda. "We are now applying this technology to the human clinical samples. I hope this tissue-clearing and 3D imaging of human samples will make diagnosis easier, more objective and accurate in near future."

Of the current limitations and potentials of the technique, co-senior author Kohei Miyazono said, “Although we cannot apply our new CUBIC-Cancer analysis to live animals, we were able to quantify metastatic cells very early in formation. This will be a very powerful tool for evaluating the effectiveness of anti-cancer drugs.”

To demonstrate how single-cell imaging of cancer metastasis could be useful for drug screening, the team treated mice with anti-cancer drugs and surveyed the results. The technique allowed them to document differences in total volume and the number of cancer colonies in the animals’ lungs - cellular evidence of the drug’s effectiveness on cancer metastasis.

"This is very promising because these cells might be dormant or resistant to anti-cancer drugs. As just one surviving cancer cell can lead to tumor metastasis, being able to use CUBIC-Cancer analysis to evaluate drug effectiveness at this level is going to be a very useful and practical application,” said Shimpei Kubota and Kei Takahashi, the study’s co-first authors.

Additional sources: RIKEN, BBC, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 04, 2019
Cancer
DEC 04, 2019
Photon up-conversion for new cancer treatments
Scientists from the University of California, Riverside and The University of Texas at Austin have made a breakthrough in materials science that has signif...
DEC 08, 2019
Cancer
DEC 08, 2019
Is there an association between smoking marijuana and cancer?
The controversy with marijuana is only likely to continue as research studies try to understand if marijuana use is associated to an increased risk of canc...
DEC 23, 2019
Cancer
DEC 23, 2019
Sustained weight loss over 50 reduces risk of breast cancer
Research published recently in the Journal of National Cancer Institute suggests a new form of cancer prevention: losing weight and keeping it off. This st...
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 20, 2020
Neuroscience
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
Loading Comments...